Alzheimer's Disease Clinical Trial
Official title:
Reminiscence, Anxiety and Early Alzheimer's Disease
This study seeks to establish the acceptability and evaluate the limited efficacy of Simple
Reminiscence (SR), a home-delivered non-pharmacological intervention designed to relieve
stress, improve affect, and prevent or quell disruptive or maladaptive behaviors in
community-residing individuals diagnosed with early Alzheimer's disease (EAD). Unmanaged
episodes of anxiety can be antecedents of maladaptive behaviors, including agitation, anger,
and sometimes even violence.
SR is a dyadic strategy; both the person with EAD and the caregiver engaged the patient's
memory to interrupt a current episode of anxiety.
Through the intervention, family caregivers are trained to collaborate with and guide
patients to access positive memories as a way to manage or move past the anxiety that
plagues individuals with EAD - often arising when confronted by common complex tasks they
previously were able to perform.
During the project's first six months (phase 1), the investigators will develop a series of
4 video-vignettes illustrating dyads (including one member with EAD) managing a variety of
anxiety provoking scenarios associated with EAD (e.g., trouble reconciling a checkbook)
through the use of SR.
During the second phase of the project, a research assistant will administer SR at four home
visits. The SR intervention has three components:
1. A didactic component using the SR manual that the couple retains (15 minutes);
2. Viewing one of the brief video-vignettes illustrating the application of reminiscence
techniques (5 minutes; a different video-vignette will be viewed at each visit; and
3. Facilitation of caregiver practice in applying the techniques, using a recent example
of anxiety-linked experience of the person with EAD (10 minutes). The caregiver is
encouraged to learn and practice the techniques in order to cue and coach the person
with EAD in their use.
The attention control treatment, a Social Visit, is a 30-minute activity in which the person
with EAD, the caregiver and the research assistant (RA) review and discuss the day's
newspaper headlines. The RA will use communication techniques specifically designed to keep
the conversation present focused.
Both members of the dyad will collect saliva to evaluate diurnal cortisol secretion.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Withdrawn |
NCT03316898 -
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
|
Phase 1 | |
Withdrawn |
NCT02860065 -
CPC-201 Alzheimer's Disease Type Dementia: PET Study
|
Phase 2 | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Recruiting |
NCT05607615 -
A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
|
Phase 2 | |
Terminated |
NCT03307993 -
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease
|
Phase 1 | |
Recruiting |
NCT02912936 -
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
|
N/A | |
Active, not recruiting |
NCT02899091 -
Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02868905 -
Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women
|
N/A | |
Completed |
NCT02907567 -
Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT02580305 -
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
|
Phase 2 | |
Completed |
NCT02516046 -
18F-AV-1451 Autopsy Study
|
Phase 3 | |
Terminated |
NCT02521558 -
Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease
|
N/A | |
Recruiting |
NCT02247180 -
Cognitive Rehabilitation in Alzheimer`s Disease
|
N/A | |
Completed |
NCT02317523 -
Alzheimer's Caregiver Coping: Mental and Physical Health
|
N/A | |
Completed |
NCT02256306 -
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
|
N/A | |
Completed |
NCT02260167 -
Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
|
N/A | |
Terminated |
NCT02220738 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
|
Phase 1 | |
Completed |
NCT01922258 -
Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
|
Phase 3 |